63,803
Views
83
CrossRef citations to date
0
Altmetric
Articles

Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being

, M.Sc., Ph.D. ORCID Icon, , Ph.D., , M.Sc., Ph.D. & , Ph.D. ORCID Icon
Pages 123-134 | Received 23 Oct 2018, Accepted 18 Jan 2019, Published online: 26 Feb 2019

References

  • Aldao, A., S. Nolen-Hoeksema, and S. Schweizer. 2010. Emotion-regulation strategies across psychopathology: A meta-analytic review. Clinical Psychology Review 30 (2):217–37. doi:10.1016/j.cpr.2009.11.004.
  • Ashby, F. G., A. M. Isen, and A. U. Turken. 1999. A neuropsychological theory of positive affect and its influence on cognition. Psychological Review 106 (3):529–50.
  • Baas, M., C. K. De Dreu, and B. A. Nijstad. 2008. A meta-analysis of 25 years of mood-creativity research: Hedonic tone, activation, or regulatory focus? Psychological Bulletin 134 (6):779–806. doi:10.1037/a0012815.
  • Barbosa, P. C., I. M. Cazorla, J. S. Giglio, and R. Strassman. 2009. A six-month prospective evaluation of personality traits, psychiatric symptoms and quality of life in ayahuasca-naive subjects. Journal of Psychoactive Drugs 41 (3):205–12. doi:10.1080/02791072.2009.10400530.
  • Barbosa, P. C., J. S. Giglio, and P. Dalgalarrondo. 2005. Altered states of consciousness and short-term psychological after-effects induced by the first time ritual use of ayahuasca in an urban context in Brazil. Journal of Psychoactive Drugs 37 (2):193–201. doi:10.1080/02791072.2005.10399801.
  • Beck, A. T. 1967. Depression: Clinical, experimental, and theoretical aspects. Philadelphia: University of Pennsylvania Press.
  • Bouso, J. C., R. Doblin, M. Farre, M. A. Alcazar, and G. Gomez-Jarabo. 2008. MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder. Journal of Psychoactive Drugs 40 (3):225–36. doi:10.1080/02791072.2008.10400637.
  • Bouso, J. C., D. González, S. Fondevila, M. Cutchet, X. Fernández, P. C. R. Barbosa, M. A. Alcázar-Córcoles, W. S. Araújo, M. J. Barbanoj, and J. M. Fábregas. 2012. Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of ayahuasca: A longitudinal study. PloS One 7 (8):e42421. doi:10.1371/journal.pone.0042421.
  • Carhart-Harris, R. L., M. Bolstridge, J. Rucker, C. M. J. Day, D. Erritzoe, M. Kaelen, M. Bloomfield, J. Rickard, B. Forbes, A. Feilding, et al. 2016. Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study. The Lancet Psychiatry 3 (7):619–27. doi:10.1016/S2215-0366(16)30065-7.
  • Carhart-Harris, R. L., D. Erritzoe, T. Williams, J. M. Stone, L. J. Reed, A. Colasanti, R. J. Tyacke, R. Leech, A. L. Malizia, K. Murphy, et al. 2012. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proceedings of the National Academy of Sciences 109 (6):2138–43. doi:10.1073/pnas.1119598109.
  • Carlozzi, A. F., K. S. Bull, G. T. Eells, and J. D. Hurlburt. 1995. Empathy as related to creativity, dogmatism, and expressiveness. The Journal of Psychology 129 (4):365–73. doi:10.1080/00223980.1995.9914974.
  • Chamberlain, S. R., N. A. Fineberg, A. D. Blackwell, T. W. Robbins, and B. J. Sahakian. 2006. Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. The American Journal of Psychiatry 163 (7):1282–84. doi:10.1176/appi.ajp.163.7.1282.
  • Colzato, L., A. Szapora, and B. Hommel. 2012. Meditate to create: The impact of focused-attention and open-monitoring training on convergent and divergent thinking. Frontiers in Psychology 3 (116). doi: 10.3389/fpsyg.2012.00116.
  • Cusi, A. M., G. M. Macqueen, R. R. Spreng, and M. C. McKinnon. 2011. Altered empathic responding in major depressive disorder: Relation to symptom severity, illness burden, and psychosocial outcome. Psychiatry Research 188 (2):231–36. doi:10.1016/j.psychres.2011.04.013.
  • Davis, M. A. 2009. Understanding the relationship between mood and creativity: A meta-analysis. Organizational Behavior and Human Decision Processes 108 (1):25–38. doi:10.1016/j.obhdp.2008.04.001.
  • Davis, M. H. 1980. A multidimensional approach to individual differences in empathy.JSAS Catalog of Selected Documents in Psychology 10, 85
  • Decety, J., I. B. A. Bartal, F. Uzefovsky, and A. Knafo-Noam. 2016. Empathy as a driver of prosocial behaviour: Highly conserved neurobehavioural mechanisms across species. Philosophical Transactions of the Royal Society B: Biological Sciences 371 (1686):20150077. doi:10.1098/rstb.2015.0077.
  • Derntl, B., E. M. Seidel, F. Schneider, and U. Habel. 2012. How specific are emotional deficits? A comparison of empathic abilities in schizophrenia, bipolar and depressed patients. Schizophrenia Research 142 (1):58–64. doi:10.1016/j.schres.2012.09.020.
  • Deutsch, F., and R. A. Madle. 1975. Empathy: Historic and current conceptualizations, measurement, and a cognitive theoretical perspective. Human Development 18 (4):267–87.
  • Diener, E., R. A. Emmons, R. J. Larsen, and S. Griffin. 1985. The satisfaction with life scale. Journal of Personality Assessment 49 (1):71–75. doi:10.1207/s15327752jpa4901_13.
  • Dolder, P. C., Y. Schmid, F. Müller, S. Borgwardt, and M. E. Liechti. 2016. LSD acutely impairs fear recognition and enhances emotional empathy and sociality. Neuropsychopharmacology 41 (11):2638. doi:10.1038/npp.2016.82.
  • Donges, U. S., A. Kersting, U. Dannlowski, J. Lalee-Mentzel, V. Arolt, and T. Suslow. 2005. Reduced awareness of others’ emotions in unipolar depressed patients. The Journal of Nervous and Mental Disease 193 (5):331–37.
  • Dos Santos, R. G., F. L. Osório, J. A. S. Crippa, J. Riba, A. W. Zuardi, and J. E. C. Hallak. 2016. Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): A systematic review of clinical trials published in the last 25 years. Ther Adv Psychopharmacol 6 (3):193–213. doi:10.1177/2045125316638008.
  • Dziobek, I., K. Rogers, S. Fleck, M. Bahnemann, H. R. Heekeren, O. T. Wolf, and A. Convit. 2008. Dissociation of cognitive and emotional empathy in adults with Asperger syndrome using the Multifaceted Empathy Test (MET). Journal of Autism and Developmental Disorders 38 (3):464–73. doi:10.1007/s10803-007-0486-x.
  • Erowid. 2015. Mushroom tea preparation. Erowid.org. Accessed October 15, 2018. https://erowid.org/plants/mushrooms/mushrooms_prep2.shtml.
  • Eslinger, P. J. 1998. Neurological and neuropsychological bases of empathy. European Neurology 39 (4):193–99. doi:10.1159/000007933.
  • Forgeard, M. J. C., and K. V. Eichner. 2014. “Creativity as a target and tool for positive interventions”. In The Wiley Blackwell handbook of positive psychological interventions, edited by A. C. Parks & S. M. Schueller, 137–54. Wiley-Blackwell.
  • Forgeard, M. J. C., and J. G. Elstein. 2014. Advancing the clinical science of creativity. Frontiers in Psychology 5:613. doi:10.3389/fpsyg.2014.00613.
  • Frecska, E., P. Bokor, and M. Winkelman. 2016. The therapeutic potentials of ayahuasca: possible effects against various diseases of civilization. Frontiers in Pharmacology 7:35. doi:10.3389/fphar.2016.00035.
  • Frecska, E., C. E. Móré, A. Vargha, and L. E. Luna. 2012. Enhancement of creative expression and entoptic phenomena as after-effects of repeated ayahuasca ceremonies. Journal of Psychoactive Drugs 44 (3):191–99. doi:10.1080/02791072.2012.703099.
  • Garcia-Romeu, A., R. R. Griffiths, and M. W. Johnson. 2015. Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction. Current Drug Abuse Reviews 7 (3):157–64. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342293/.
  • Gleichgerrcht, E., and J. Decety. 2013. Empathy in clinical practice: How individual dispositions, gender, and experience moderate empathic concern, burnout, and emotional distress in physicians. PloS One 8 (4):e61526. doi:10.1371/journal.pone.0061526.
  • Griffiths, R. R., M. W. Johnson, M. A. Carducci, A. Umbricht, W. A. Richards, B. D. Richards, M. P. Cosimano, and M. A. Klinedinst. 2016. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology 30 (12):1181–97. doi:10.1177/0269881116675513.
  • Griffiths, R. R., M. W. Johnson, W. A. Richards, B. D. Richards, U. McCann, and R. Jesse. 2011. Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects. Psychopharmacology 218 (4):649–65. doi:10.1007/s00213-011-2358-5.
  • Griffiths, R. R., W. A. Richards, U. McCann, and R. Jesse. 2006. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology. 187 (3):268–83. discussion 284-92. doi:10.1007/s00213-006-0457-5.
  • Grob, C. S., A. L. Danforth, G. S. Chopra, M. Hagerty, C. R. McKay, A. L. Halberstadt, and G. R. Greer. 2011. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Archives of General Psychiatry 68 (1):71–78. doi:10.1001/archgenpsychiatry.2010.116.
  • Guilford, J. P. 1967. The nature of human intelligence. New York, NY, US: McGraw-Hill.
  • Harman, W. W., R. H. McKim, R. E. Mogar, J. Fadiman, and M. J. Stolaroff. 1966. Psychedelic agents in creative problem-solving: A pilot study. Psychological Reports 19 (1):211–27. doi:10.2466/pr0.1966.19.1.211.
  • Hasler, F., U. Grimberg, M. A. Benz, T. Huber, and F. X. Vollenweider. 2004. Acute psychological and physiological effects of psilocybin in healthy humans: A double-blind, placebo-controlled dose–Effect study. Psychopharmacology 172 (2):145–56. doi:10.1007/s00213-003-1640-6.
  • Hurlemann, R., A. Patin, O. A. Onur, M. X. Cohen, T. Baumgartner, S. Metzler, I. Dziobek, J. Gallinat, M. Wagner, W. Maier, et al. 2010. Oxytocin enhances amygdala-dependent, socially reinforced learning and emotional empathy in humans. The Journal of Neuroscience 30 (14):4999–5007. doi:10.1523/jneurosci.5538-09.2010.
  • Hysek, C. M., Y. Schmid, L. D. Simmler, G. Domes, M. Heinrichs, C. Eisenegger, K. H. Preller, B. B. Quednow, and M. E. Liechti. 2014. MDMA enhances emotional empathy and prosocial behavior. Social Cognitive and Affective Neuroscience 9 (11):1645–52. doi:10.1093/scan/nst161.
  • Johnson, M. W., A. Garcia-Romeu, and R. R. Griffiths. 2017. Long-term follow-up of psilocybin-facilitated smoking cessation. The American Journal of Drug and Alcohol Abuse 43 (1):55–60. doi:10.3109/00952990.2016.1170135.
  • Kometer, M., A. Schmidt, R. Bachmann, E. Studerus, E. Seifritz, and F. X. Vollenweider. 2012. Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors. Biological Psychiatry 72 (11):898–906. doi:10.1016/j.biopsych.2012.04.005.
  • Krippner, S. 1964. The hypnotic trance, the psychedelic experience, and the creative act. American Journal of Clinical Hypnosis 7 (2):140–47. doi:10.1080/00029157.1964.10402408.
  • Kuypers, K. P. C. 2018. Out of the box: A psychedelic model to study the creative mind. Medical Hypotheses 115:13–16. doi:10.1016/j.mehy.2018.03.010.
  • Kuypers, K. P. C., R. de la Torre, M. Farre, S. Yubero-Lahoz, I. Dziobek, W. van Den Bos, and J. G. Ramaekers. 2014. No evidence that MDMA-induced enhancement of emotional empathy is related to peripheral oxytocin levels or 5-HT1a receptor activation. PloS One 9 (6):e100719. doi:10.1371/journal.pone.0100719.
  • Kuypers, K. P. C., P. C. Dolder, J. G. Ramaekers, and M. E. Liechti. 2017. Multifaceted empathy of healthy volunteers after single doses of MDMA: A pooled sample of placebo-controlled studies. Journal of Psychopharmacology 31 (5):589–98. doi:10.1177/0269881117699617.
  • Kuypers, K. P. C., J. Riba, M. de la Fuente Revenga, S. Barker, E. L. Theunissen, and J. G. Ramaekers. 2016. Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking. Psychopharmacology 233 (18):3395–403. doi:10.1007/s00213-016-4377-8.
  • Laussmann, T., and S. Meier-Giebing. 2010. Forensic analysis of hallucinogenic mushrooms and khat (Catha edulisForsk) using cation-exchange liquid chromatography. Forensic Science International 195 (1):160–64. doi:10.1016/j.forsciint.2009.12.013.
  • Lawn, W., J. E. Hallak, J. A. Crippa, R. Dos Santos, L. Porffy, M. J. Barratt, J. A. Ferris, A. R. Winstock, and C. J. A. Morgan. 2017. Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: A large, international, self-selecting online survey. Scientific Reports 7 (1):15201. doi:10.1038/s41598-017-14700-6.
  • Lee, J. K., and S. M. Orsillo. 2014. Investigating cognitive flexibility as a potential mechanism of mindfulness in Generalized Anxiety Disorder. Journal of Behavior Therapy and Experimental Psychiatry 45 (1):208–16. doi:10.1016/j.jbtep.2013.10.008.
  • Morelli, S. A., M. D. Lieberman, and J. Zaki. 2015. The emerging study of positive empathy. Social and Personality Psychology Compass 9 (2):57–68. doi:10.1111/spc3.v9.2.
  • Morrison, A. S., M. A. Mateen, F. A. Brozovich, J. Zaki, P. R. Goldin, R. G. Heimberg, and J. J. Gross. 2016. Empathy for positive and negative emotions in social anxiety disorder. Behaviour Research and Therapy 87:232–42. doi:10.1016/j.brat.2016.10.005.
  • Neumann, M., F. Edelhäuser, D. Tauschel, M. R. Fischer, M. Wirtz, C. Woopen, A. Haramati, and C. Scheffer. 2011. Empathy decline and its reasons: A systematic review of studies with medical students and residents. Academic Medicine 86 (8):996–1009. doi:10.1097/ACM.0b013e318221e615.
  • Nietlisbach, G., and A. Maercker. 2009. Social cognition and interpersonal impairments in trauma survivors with PTSD. Journal of Aggression, Maltreatment & Trauma 18 (4):382–402. doi:10.1080/10926770902881489.
  • Nietlisbach, G., A. Maercker, W. Rossler, and H. Haker. 2010. Are empathic abilities impaired in posttraumatic stress disorder? Psychological Reports 106 (3):832–44. doi:10.2466/pr0.106.3.832-844.
  • Osorio, F. L., R. F. Sanches, L. R. Macedo, R. G. Santos, J. P. Maia-de-Oliveira, L. Wichert-Ana, D. B. Araujo, J. Riba, J. A. Crippa, and J. E. Hallak. 2015. Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: A preliminary report. Revista brasileira de psiquiatria 37 (1):13–20. doi:10.1590/1516-4446-2014-1496.
  • Palgi, S., E. Klein, and S. G. Shamay-Tsoory. 2016. Oxytocin improves compassion toward women among patients with PTSD. Psychoneuroendocrinology 64:143–49. doi:10.1016/j.psyneuen.2015.11.008.
  • Palm, K. M., and V. M. Follette. 2011. The roles of cognitive flexibility and experiential avoidance in explaining psychological distress in survivors of interpersonal victimization. Journal of Psychopathology and Behavioral Assessment 33 (1):79–86. doi:10.1007/s10862-010-9201-x.
  • Parlar, M., P. Frewen, A. Nazarov, C. Oremus, G. MacQueen, R. Lanius, and M. C. McKinnon. 2014. Alterations in empathic responding among women with posttraumatic stress disorder associated with childhood trauma. Brain and Behavior 4 (3):381–89. doi:10.1002/brb3.215.
  • Pavot, W., and E. Diener. 2013. The Satisfaction with Life Scale (SWL). Measurement instrument database for the social science. www.midss.ie.
  • Pavot, W., E. Diener, C. R. Colvin, and E. Sandvik. 1991. Further validation of the Satisfaction with Life Scale: Evidence for the cross-method convergence of well-being measures. Journal of Personality Assessment 57 (1):149–61. doi:10.1207/s15327752jpa5701_17.
  • Pavot, W., and E. Diener. 2009. “Review of the satisfaction with life scale”. In Social Indicators Research Series: Vol. 39. Assessing Well-Being: The Collected Works of Ed Diener (pp. 101–117). New York, NY: Springer Science + Business Media.
  • Pokorny, T., K. H. Preller, M. Kometer, I. Dziobek, and F. X. Vollenweider. 2017. Effect of psilocybin on empathy and moral decision-making. International Journal of Neuropsychopharmacology 20 (9):747–57. doi:10.1093/ijnp/pyx047.
  • Preller, K. H., T. Pokorny, R. Krähenmann, I. Dziobek, P. Stämpfli, and F. X. Vollenweider. 2015. The effect of 5-HT2A/1a agonist treatment on social cognition, empathy, and social decision-making. European Psychiatry 30:22. doi:10.1016/j.eurpsy.2014.02.004.
  • Prochazkova, L., D. P. Lippelt, L. S. Colzato, M. Kuchar, Z. Sjoerds, and B. Hommel. 2018. Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting. Psychopharmacology 235 (12):3401–13. doi:10.1007/s00213-018-5049-7.
  • Runco, M. A., and S. Acar. 2012. Divergent thinking as an indicator of creative potential. Creativity Research Journal 24 (1):66–75. doi:10.1080/10400419.2012.652929.
  • Schmid, Y., C. M. Hysek, L. D. Simmler, M. J. Crockett, B. B. Quednow, and M. E. Liechti. 2014. Differential effects of MDMA and methylphenidate on social cognition. Journal of Psychopharmacology 28 (9):847–56. doi:10.1177/0269881114542454.
  • Sessa, B. 2008. Is it time to revisit the role of psychedelic drugs in enhancing human creativity? Journal of Psychopharmacology 22 (8):821–27. doi:10.1177/0269881108091597.
  • Shewan, D., P. Dalgarno, and G. Reith. 2000. Perceived risk and risk reduction among ecstasy users: The role of drug, set, and setting. International Journal of Drug Policy 10 (6):431–53. doi:10.1016/S0955-3959(99)00038-9.
  • Thomas, G., P. Lucas, N. R. Capler, K. W. Tupper, and G. Martin. 2013. Ayahuasca-assisted therapy for addiction: Results from a preliminary observational study in Canada. Current Drug Abuse Reviews 6 (1):30–42.
  • Thomas, M. R., L. N. Dyrbye, J. L. Huntington, K. L. Lawson, P. J. Novotny, J. A. Sloan, and T. D. Shanafelt. 2007. How do distress and well-being relate to medical student empathy? A multicenter study. Journal of General Internal Medicine 22 (2):177–83. doi:10.1007/s11606-006-0039-6.
  • Todd, A. R., M. Forstmann, P. Burgmer, A. W. Brooks, and A. D. Galinsky. 2015. Anxious and egocentric: How specific emotions influence perspective taking. Journal of Experimental Psychology General 144 (2):374–91. doi:10.1037/xge0000048.
  • Uthaug, M. V., K. van Oorsouw, K. P. C. Kuypers, M. van Boxtel, N. J. Broers, N. L. Mason, S. W. Toennes, J. Riba, and J. G. Ramaekers. 2018. Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution. Psychopharmacology 235(10): 2979-2989.
  • Valle, M., A. E. Maqueda, M. Rabella, A. Rodriguez-Pujadas, R. M. Antonijoan, S. Romero, J. F. Alonso, M. A. Mananas, S. S. Barker, P. P. Friedlander, et al. 2016. Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans. European Neuropsychopharmacology 26 (7):1161–75. doi:10.1016/j.euroneuro.2016.03.012.